Sexual Dysfunction — MCQs
On this page
What is the most accurate treatment for erectile dysfunction?
A 22-year-old nulliparous woman, recently sexually active, presents with dyspareunia localized to the vaginal introitus, accompanied by involuntary pelvic muscle contractions. Her pelvic examination is otherwise normal. What is the most common cause of this condition?
Which of the following statements about erectile dysfunction are false?
A 25-year-old woman presents with complaints of pain during intercourse for 2 months, which occurs with initial penetration and continues throughout the entire episode. She reports a previously pleasurable, pain-free relationship with her husband. Her prior investigations, including pelvic examination, Pap smear with cultures, and pelvic sonogram, were normal. She also admits to vaginal dryness and low libido during the same timeframe. She reveals that she discovered her husband's infidelity 2 months ago. What is the most appropriate recommendation for this patient?
Which of the following may be used in erectile dysfunction except?
What is the most accurate treatment for erectile dysfunction?
A 23-year-old nulliparous woman complains of painful coitus, with the pain located at the vaginal introitus. This is accompanied by painful involuntary contractions of the pelvic muscles. Pelvic examination is normal, and no obvious local pathology is seen. What is the most common cause of this condition?
A 30-year-old male presents with erectile dysfunction. Basic screening evaluation is unremarkable. What is the next step in evaluation or management?
What is the drug of choice for hypoactive sexual desire disorder in females?
A postoperative male client with diabetes mellitus reports impotence and expresses concern about its effect on his marriage. In planning this client's care, what is the most appropriate intervention?
Sexual Dysfunction Indian Medical PG Practice Questions and MCQs
Question 1: What is the most accurate treatment for erectile dysfunction?
- A. Sildenafil (Correct Answer)
- B. Masters and Johnson technique
- C. Beta-blockers
- D. Papaverine
Explanation: **Explanation:** **Sildenafil (Option A)** is the correct answer as it is the **first-line pharmacological treatment** for erectile dysfunction (ED). It is a selective **Phosphodiesterase-5 (PDE-5) inhibitor**. By inhibiting PDE-5, it prevents the degradation of cyclic Guanosine Monophosphate (cGMP) in the corpus cavernosum. Increased cGMP levels lead to smooth muscle relaxation and increased blood flow, facilitating an erection in response to sexual stimulation. **Analysis of Incorrect Options:** * **Masters and Johnson technique (Option B):** This refers to behavioral "sensate focus" exercises. While useful for psychogenic ED or premature ejaculation, it is not the primary or most accurate medical treatment for organic ED. * **Beta-blockers (Option C):** These are actually a known **cause** of erectile dysfunction (a common side effect of Propranolol) rather than a treatment. * **Papaverine (Option D):** This is a vasodilator that can be used via intracavernosal injection. However, it is considered second-line therapy due to the risk of priapism and the invasive nature of administration compared to oral Sildenafil. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** PDE-5 inhibitors are strictly contraindicated in patients taking **Nitrates** (e.g., Nitroglycerin) due to the risk of severe, life-threatening hypotension. * **Common Side Effects:** Headache, flushing, and dyspepsia. A unique side effect is **Cyanopsia** (blue-tinted vision) due to weak inhibition of PDE-6 in the retina. * **Timing:** Sildenafil should be taken approximately 60 minutes before sexual activity, preferably on an empty stomach.
Question 2: A 22-year-old nulliparous woman, recently sexually active, presents with dyspareunia localized to the vaginal introitus, accompanied by involuntary pelvic muscle contractions. Her pelvic examination is otherwise normal. What is the most common cause of this condition?
- A. Endometriosis
- B. Psychogenic causes (Correct Answer)
- C. Bartholin's gland abscess
- D. Vulvar atrophy
Explanation: ### Explanation The clinical presentation of involuntary pelvic muscle contractions (specifically the pubococcygeus muscle) and localized introital dyspareunia in a young, nulliparous woman is classic for **Vaginismus**. **1. Why Psychogenic Causes are Correct:** Vaginismus is primarily a psychophysiological condition. While physical triggers can exist, the **most common underlying cause is psychogenic**, often rooted in "fear-avoidance" cycles. Factors include sexual trauma, negative attitudes toward sex, or fear of pain/pregnancy. This leads to a conditioned reflex where the pelvic floor muscles contract involuntarily in anticipation of penetration, making entry painful or impossible despite normal anatomy. **2. Why Other Options are Incorrect:** * **Endometriosis (A):** Typically causes **deep dyspareunia** (pain on deep thrusting) rather than introital pain, and is often associated with dysmenorrhea and chronic pelvic pain. * **Bartholin’s Gland Abscess (C):** This presents as an acute, extremely painful, fluctuant swelling at the 4 or 8 o'clock position of the vaginal vestibule. It is an inflammatory/infectious condition, not a muscle contraction disorder. * **Vulvar Atrophy (D):** This is a common cause of dyspareunia in **postmenopausal** women due to estrogen deficiency. It is highly unlikely in a 22-year-old with a normal pelvic exam. **3. NEET-PG High-Yield Pearls:** * **Definition:** Vaginismus is the involuntary spasm of the outer third of the vaginal muscles. * **Diagnosis:** It is a clinical diagnosis. The pelvic exam is typically normal except for the induced spasm during attempted digital examination. * **Management:** The first-line treatment is **behavioral therapy and vaginal dilators** (Heigar’s dilators) to desensitize the reflex, often combined with counseling. * **Distinction:** Always differentiate between **Introital Dyspareunia** (Vaginismus, Vulvar Vestibulitis) and **Deep Dyspareunia** (Endometriosis, PID, Pelvic Adhesions).
Question 3: Which of the following statements about erectile dysfunction are false?
- A. Psychogenic erectile dysfunction is distinguished from organic erectile dysfunction by PIPE therapy. (Correct Answer)
- B. Sildenafil is used for treatment.
- C. Nocturnal penile tumescence is maintained in psychological erectile dysfunction.
- D. Sensate focus therapy aims at sensitizing nongenital areas.
Explanation: **Explanation:** The correct answer is **A**. This statement is false because **PIPE (Papaverine Induced Penile Erection)** therapy is used to assess the vascular integrity of the penis, but it **cannot** reliably distinguish between psychogenic and organic erectile dysfunction (ED). A positive response (erection) occurs in both psychogenic ED and mild vasculogenic ED, making it non-specific for differentiation. **Analysis of other options:** * **Option B (Sildenafil):** This is a Phosphodiesterase-5 (PDE-5) inhibitor and is the first-line pharmacological treatment for ED. It works by increasing cGMP levels, leading to smooth muscle relaxation and increased blood flow. * **Option C (Nocturnal Penile Tumescence - NPT):** This is the **gold standard** for differentiating psychogenic from organic ED. Healthy men have 3–5 spontaneous erections during REM sleep. These are **maintained** in psychogenic ED but absent or diminished in organic ED. * **Option D (Sensate Focus Therapy):** Developed by Masters and Johnson, this behavioral technique involves a series of touching exercises. It aims to reduce performance anxiety by focusing on non-genital physical sensations before progressing to genital stimulation. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of ED:** Organic (Vascular/Diabetes) in older men; Psychogenic in younger men. * **NPT Monitoring:** Often performed using a **Rigiscan** device. * **Sildenafil Contraindication:** Must never be co-administered with **Nitrates** due to the risk of severe, life-threatening hypotension. * **Alprostadil:** A PGE1 analogue used as second-line therapy (intracavernosal injection).
Question 4: A 25-year-old woman presents with complaints of pain during intercourse for 2 months, which occurs with initial penetration and continues throughout the entire episode. She reports a previously pleasurable, pain-free relationship with her husband. Her prior investigations, including pelvic examination, Pap smear with cultures, and pelvic sonogram, were normal. She also admits to vaginal dryness and low libido during the same timeframe. She reveals that she discovered her husband's infidelity 2 months ago. What is the most appropriate recommendation for this patient?
- A. Marriage counseling (Correct Answer)
- B. Estrogen vaginal cream for vaginal dryness
- C. Vaginal dilators for treatment of vaginismus
- D. Antidepressant therapy
Explanation: ### Explanation The patient is presenting with **secondary dyspareunia** (painful intercourse) and **acquired Female Sexual Interest/Arousal Disorder (FSIAD)**. The temporal relationship between the onset of symptoms and the discovery of her husband’s infidelity points toward a **psychogenic etiology** rather than a physical one. **1. Why Marriage Counseling is Correct:** In this clinical scenario, the physical examination and investigations (Pap smear, cultures, sonogram) are entirely normal, ruling out organic causes like infections, endometriosis, or atrophy. The psychological trauma of infidelity has led to a lack of emotional intimacy, resulting in decreased arousal, inadequate vaginal lubrication (dryness), and subsequent pain during penetration. **Marriage counseling** is the most appropriate first-line intervention to address the underlying relational conflict and emotional distress causing the sexual dysfunction. **2. Why Other Options are Incorrect:** * **B. Estrogen vaginal cream:** This is indicated for vulvovaginal atrophy (Genitourinary Syndrome of Menopause). This patient is 25 years old with normal anatomy; her dryness is due to lack of arousal, not estrogen deficiency. * **C. Vaginal dilators:** These are the treatment of choice for **vaginismus** (involuntary contraction of pelvic floor muscles). While she has pain, the history suggests it is secondary to a lack of lubrication and emotional factors rather than primary muscle spasms. * **D. Antidepressant therapy:** While she is distressed, there is no clinical diagnosis of Major Depressive Disorder. Furthermore, SSRIs often cause sexual side effects (delayed orgasm, decreased libido), which could worsen her condition. ### Clinical Pearls for NEET-PG: * **Primary vs. Secondary:** Primary dyspareunia occurs from the first sexual encounter; secondary occurs after a period of pain-free function. * **Vaginismus vs. Dyspareunia:** Vaginismus is a *conditioned reflex* causing muscle spasm; Dyspareunia is the *sensation* of pain. * **The Arousal-Pain Cycle:** Psychological distress leads to decreased arousal $\rightarrow$ decreased lubrication $\rightarrow$ friction/pain $\rightarrow$ anticipatory anxiety $\rightarrow$ further decreased arousal. * **Rule of Thumb:** If a patient has a sudden onset of sexual dysfunction coinciding with a major life stressor and has a normal physical exam, prioritize **psychotherapy or counseling**.
Question 5: Which of the following may be used in erectile dysfunction except?
- A. Phenylephrine (Correct Answer)
- B. Apomorphine
- C. Alprostidil
- D. All
Explanation: In the management of erectile dysfunction (ED), the goal is to promote vasodilation and smooth muscle relaxation in the corpus cavernosum. **Phenylephrine** is the correct answer because it is a selective **alpha-1 adrenergic agonist** that causes vasoconstriction. ### Why Phenylephrine is the Exception: Phenylephrine is actually used to **treat priapism** (a prolonged, painful erection), not erectile dysfunction. By stimulating alpha-receptors, it induces contraction of the cavernous smooth muscle and vasoconstriction of the arterioles, effectively terminating the erection. ### Explanation of Other Options: * **Apomorphine:** This is a dopamine (D2) receptor agonist that acts centrally on the hypothalamus to trigger the erectile response. It was historically used as a sublingual treatment for ED. * **Alprostadil:** This is a synthetic **Prostaglandin E1 (PGE1)**. It acts locally by increasing cAMP levels, leading to smooth muscle relaxation and increased blood flow. It is administered via intracavernosal injection or intraurethral pellets. ### NEET-PG High-Yield Pearls: * **First-line treatment for ED:** Oral PDE-5 inhibitors (e.g., Sildenafil, Tadalafil). * **Mechanism of Sildenafil:** Inhibits PDE-5, preventing the breakdown of cGMP, which maintains smooth muscle relaxation. * **Contraindication:** PDE-5 inhibitors must never be used with **Nitrates** due to the risk of severe, life-threatening hypotension. * **Priapism Management:** Aspiration of blood followed by intracavernosal injection of **Phenylephrine** is the standard emergency management for ischemic priapism.
Question 6: What is the most accurate treatment for erectile dysfunction?
- A. Sildenafil (Correct Answer)
- B. Master and Johnson technique
- C. Beta blockers
- D. Papaverine
Explanation: **Explanation:** **Erectile Dysfunction (ED)** is defined as the persistent inability to attain or maintain a penile erection sufficient for satisfactory sexual performance. **Why Sildenafil is correct:** Sildenafil is a selective **Phosphodiesterase-5 (PDE-5) inhibitor**. It works by inhibiting the enzyme PDE-5, which normally breaks down cyclic Guanosine Monophosphate (cGMP) in the corpus cavernosum. By preventing cGMP degradation, it enhances nitric oxide-mediated smooth muscle relaxation and increases blood flow to the penis. It is currently the **first-line pharmacological treatment** for ED due to its high efficacy and oral route of administration. **Analysis of Incorrect Options:** * **Master and Johnson technique:** This refers to behavioral therapy (e.g., "sensate focus" exercises). While useful for psychogenic sexual dysfunction or premature ejaculation, it is not the primary or most accurate treatment for organic ED. * **Beta-blockers:** These are actually a **cause** of erectile dysfunction (a known side effect), not a treatment. * **Papaverine:** This is a vasodilator that can be used via intracavernosal injection. While effective, it is considered a second-line treatment due to the risk of priapism and the invasive nature of administration compared to oral PDE-5 inhibitors. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** Sildenafil must **never** be co-administered with **Nitrates** (e.g., Nitroglycerin), as it can lead to life-threatening hypotension. * **Side Effects:** Common side effects include headache, flushing, and **cyanopsia** (blue-tinted vision) due to cross-reactivity with PDE-6 in the retina. * **Tadalafil vs. Sildenafil:** Tadalafil has a much longer half-life (approx. 17.5 hours) compared to Sildenafil (4 hours), earning it the nickname "the weekend pill."
Question 7: A 23-year-old nulliparous woman complains of painful coitus, with the pain located at the vaginal introitus. This is accompanied by painful involuntary contractions of the pelvic muscles. Pelvic examination is normal, and no obvious local pathology is seen. What is the most common cause of this condition?
- A. Endometriosis
- B. Psychological causes (Correct Answer)
- C. Bartholin's gland abscess
- D. Vulvar atrophy
Explanation: **Explanation:** The clinical presentation described—pain at the vaginal introitus accompanied by involuntary contractions of the pelvic floor muscles (specifically the pubococcygeus muscle) during attempted penetration—is the classic triad of **Vaginismus**. **Why Psychological Causes are correct:** Vaginismus is primarily a psychophysiological condition. While it can be triggered by physical pain, the most common underlying etiology involves **psychological factors** such as fear of pain, sexual trauma, strict religious upbringing, or anxiety regarding intercourse. This leads to a conditioned reflex where the body "protects" itself via involuntary muscle spasms, despite a normal physical anatomy. **Analysis of Incorrect Options:** * **Endometriosis:** Typically causes **deep dyspareunia** (pain deep in the pelvis) rather than introital pain, and is often associated with dysmenorrhea and pelvic masses. * **Bartholin’s Gland Abscess:** This would present with a visible, exquisitely tender, fluctuant swelling at the 4 or 8 o'clock position of the labia majora. The question states the pelvic examination is **normal**. * **Vulvar Atrophy:** Common in postmenopausal women due to estrogen deficiency. It is highly unlikely in a 23-year-old nulliparous woman and would show physical signs like thinning of the mucosa. **Clinical Pearls for NEET-PG:** * **Vaginismus vs. Dyspareunia:** Vaginismus is the *involuntary contraction* preventing entry; Dyspareunia is *pain* during intercourse. * **Management:** The first-line treatment for Vaginismus is **behavioral therapy** and the use of **graded vaginal dilators** (Hegar’s dilators) combined with relaxation techniques. * **Primary vs. Secondary:** Primary vaginismus occurs when a woman has never been able to achieve penetration; secondary occurs after a period of normal function.
Question 8: A 30-year-old male presents with erectile dysfunction. Basic screening evaluation is unremarkable. What is the next step in evaluation or management?
- A. Oral sildenafil trial (Correct Answer)
- B. Cavernosometry
- C. Doppler study
- D. Neurological testing
Explanation: **Explanation:** The management of erectile dysfunction (ED) follows a stepwise approach. In a 30-year-old patient where the basic screening (history, physical exam, and baseline labs like glucose and testosterone) is unremarkable, the most likely etiology is either psychogenic or early vasculogenic. **1. Why Oral Sildenafil is the correct next step:** Current clinical guidelines (AUA/EAU) recommend a **trial of Oral Phosphodiesterase-5 (PDE5) inhibitors**, such as Sildenafil, as both a first-line treatment and a diagnostic tool. If the patient responds well to Sildenafil, it confirms that the corporal tissue is functional and the blood supply is sufficient, often obviating the need for invasive, expensive, or specialized testing. **2. Why other options are incorrect:** * **Doppler study (Option C):** Penile Duplex Ultrasound is indicated only if the patient fails oral therapy or if there is a history of pelvic trauma/Peyronie’s disease. It is not a first-line investigation. * **Cavernosometry (Option B):** This is a highly invasive procedure used to diagnose venous leak (venous-occlusive dysfunction). It is reserved for surgical candidates and is never a primary step. * **Neurological testing (Option D):** This is indicated only if there is a specific history of spinal cord injury, pelvic surgery, or abnormal findings on neurological examination (e.g., decreased perianal sensation). **Clinical Pearls for NEET-PG:** * **First-line treatment for ED:** Lifestyle modifications + PDE5 inhibitors. * **Mechanism of Sildenafil:** Inhibits PDE5, increasing **cGMP** levels, leading to smooth muscle relaxation and increased blood flow. * **Contraindication:** Never co-administer PDE5 inhibitors with **Nitrates** (risk of severe hypotension). * **Psychogenic ED:** Characterized by sudden onset and the presence of **nocturnal/morning erections**.
Question 9: What is the drug of choice for hypoactive sexual desire disorder in females?
- A. Kitanserine
- B. Sildenafil
- C. Modafinil
- D. Flibanserin (Correct Answer)
Explanation: **Explanation:** **Hypoactive Sexual Desire Disorder (HSDD)** in females is characterized by a persistent or recurrent deficiency of sexual fantasies and desire for sexual activity, causing marked distress. **1. Why Flibanserin is the Correct Answer:** Flibanserin is the first FDA-approved drug specifically for the treatment of HSDD in premenopausal women. It is a **multifunctional serotonin agonist-antagonist (MSAA)**. It acts as a **5-HT1A receptor agonist** and a **5-HT2A receptor antagonist**. By modulating these neurotransmitters, it increases dopamine and norepinephrine (pro-sexual excitants) while decreasing serotonin (a sexual inhibitor) in the prefrontal cortex, thereby enhancing sexual desire. **2. Why the Other Options are Incorrect:** * **Kitanserin:** This is a selective 5-HT2 receptor antagonist used primarily as an antihypertensive agent. It has no clinical role in treating female sexual dysfunction. * **Sildenafil:** A PDE-5 inhibitor used for erectile dysfunction in men. While it increases pelvic blood flow, clinical trials have shown it is **not effective** for treating desire disorders (HSDD) in women. * **Modafinil:** A wakefulness-promoting agent used for narcolepsy and shift-work sleep disorder. It does not have a primary indication for sexual dysfunction. **High-Yield Clinical Pearls for NEET-PG:** * **Bremelanotide:** Another approved treatment for HSDD; it is a **Melanocortin receptor agonist** administered via subcutaneous injection. * **Contraindication:** Flibanserin should not be taken with **alcohol** due to the risk of severe hypotension and syncope (though recent FDA updates have slightly relaxed the timing of consumption). * **Administration:** Unlike Sildenafil (taken on-demand), Flibanserin must be taken **daily at bedtime** to reduce the risk of sedation and hypotension.
Question 10: A postoperative male client with diabetes mellitus reports impotence and expresses concern about its effect on his marriage. In planning this client's care, what is the most appropriate intervention?
- A. Encourage the client to ask questions about personal sexuality.
- B. Provide time for privacy.
- C. Provide support for the spouse or significant other.
- D. Suggest referral to a sex counselor or other appropriate professional. (Correct Answer)
Explanation: **Explanation:** **1. Why Option D is Correct:** Impotence (Erectile Dysfunction) in a diabetic patient is often multifactorial, involving **organic causes** (diabetic neuropathy and microvascular disease) and **psychological factors** (postoperative stress and anxiety regarding marital impact). Managing sexual dysfunction requires specialized knowledge to differentiate between these causes and to provide targeted therapies (e.g., PDE5 inhibitors, vacuum devices, or psychosexual therapy). A referral to a sex counselor or a urologist specializing in sexual medicine is the most appropriate intervention because it ensures the patient receives expert, comprehensive care beyond the scope of general postoperative nursing or medical management. **2. Why Other Options are Incorrect:** * **Option A & B:** While encouraging communication and providing privacy are essential components of therapeutic communication, they are **supportive measures** rather than definitive interventions. They do not address the underlying physiological or complex psychological roots of the dysfunction. * **Option C:** Supporting the spouse is important for holistic care, but the primary focus must remain on diagnosing and treating the patient’s clinical condition first. **3. Clinical Pearls for NEET-PG:** * **Diabetes & ED:** Diabetes is the most common organic cause of Erectile Dysfunction. It involves a combination of decreased nitric oxide bioavailability (endothelial dysfunction) and autonomic neuropathy. * **Screening:** Always rule out reversible causes like medications (Beta-blockers, SSRIs) or hormonal imbalances (Hypogonadism/Hyperprolactinemia). * **First-line Treatment:** Lifestyle modifications and oral PDE5 inhibitors (e.g., Sildenafil), provided there are no contraindications like nitrate use. * **Psychogenic vs. Organic:** If a patient maintains nocturnal penile tumescence (morning erections), the cause is likely psychogenic rather than organic.
Question 11: Which of the following medications is approved for the treatment of Hypoactive Sexual Desire Disorder in premenopausal females?
- A. Flibanserin (Correct Answer)
- B. Sildenafil
- C. Alprostadil
- D. Papaverine
Explanation: **Explanation:** **Hypoactive Sexual Desire Disorder (HSDD)** is characterized by a persistent or recurrent deficiency of sexual fantasies and desire for sexual activity that causes marked distress. **Why Flibanserin is Correct:** **Flibanserin** is the first FDA-approved medication specifically for HSDD in **premenopausal** women. It is a **multifunctional serotonin agonist-antagonist (MSAA)**. It acts as a 5-HT1A receptor agonist and a 5-HT2A receptor antagonist. By modulating these neurotransmitters, it increases dopamine and norepinephrine (excitatory signals for sexual desire) while decreasing serotonin (inhibitory signal). It must be taken daily at bedtime. **Why the Other Options are Incorrect:** * **Sildenafil:** A PDE-5 inhibitor used primarily for erectile dysfunction in men. While it increases genital blood flow, it has not shown significant efficacy in treating desire disorders (HSDD) in women. * **Alprostadil & Papaverine:** These are vasodilators used in the treatment of male erectile dysfunction, often via intracavernosal injection. They do not address the neurochemical pathways of sexual desire. **High-Yield NEET-PG Pearls:** * **Bremelanotide:** Another approved treatment for HSDD in premenopausal women. Unlike Flibanserin, it is a **Melanocortin receptor agonist** administered as a subcutaneous injection on an "as-needed" basis before sexual activity. * **Contraindication:** Flibanserin carries a boxed warning regarding severe hypotension and syncope when taken with **alcohol**, though recent guidelines have slightly relaxed the timing of consumption. * **Diagnosis:** HSDD is only diagnosed if the lack of desire is not due to a co-existing psychiatric condition, relationship issues, or medication side effects (e.g., SSRIs).
Question 12: Flibanserin is used in the treatment of:
- A. Female hypoactive sexual desire disorder (Correct Answer)
- B. Erectile dysfunction
- C. Anorgasmia
- D. Dyspareunia
Explanation: **Explanation:** **Flibanserin** is the first FDA-approved medication specifically indicated for the treatment of **Hypoactive Sexual Desire Disorder (HSDD)** in premenopausal women. HSDD is characterized by a persistent or recurrent deficiency of sexual fantasies and desire for sexual activity that causes marked distress. **Mechanism of Action:** Flibanserin is a **multifunctional serotonin agonist-antagonist (MSAA)**. It acts as a **5-HT1A receptor agonist** and a **5-HT2A receptor antagonist**. By modulating these receptors, it decreases serotonin (which inhibits sexual desire) and increases dopamine and norepinephrine (which promote sexual excitation) in the prefrontal cortex. **Analysis of Incorrect Options:** * **B. Erectile dysfunction:** This is primarily treated with Phosphodiesterase-5 (PDE-5) inhibitors like Sildenafil or Tadalafil, which act on the nitric oxide pathway. * **C. Anorgasmia:** While sometimes associated with HSDD, anorgasmia is a separate orgasmic disorder. There is currently no FDA-approved drug specifically for anorgasmia. * **D. Dyspareunia:** Painful intercourse in postmenopausal women is typically treated with lubricants, local estrogen therapy, or **Ospemifene** (a selective estrogen receptor modulator). **High-Yield Clinical Pearls for NEET-PG:** * **Trade Name:** Addyi (often called the "Female Viagra," though its mechanism is central, not peripheral). * **Dosing:** It must be taken **daily at bedtime** to mitigate side effects like somnolence and dizziness. * **Black Box Warning:** Significant risk of **severe hypotension and syncope** when taken with **alcohol**. It is also contraindicated with strong CYP3A4 inhibitors. * **Bremelanotide:** Another drug for HSDD, but unlike Flibanserin, it is a melanocortin receptor agonist administered via subcutaneous injection on an as-needed basis.
Question 13: Which of the following agents is most specifically used for the treatment of erectile disorder in males?
- A. Sildenafil (Correct Answer)
- B. Diazepam
- C. Fluoxetine
- D. Zolpidem
Explanation: **Explanation:** **Sildenafil** is the correct answer as it is a potent and selective inhibitor of **phosphodiesterase type 5 (PDE5)**. In the presence of sexual stimulation, nitric oxide (NO) is released in the corpus cavernosum, which activates guanylate cyclase to produce cyclic guanosine monophosphate (cGMP). cGMP causes smooth muscle relaxation and increased blood flow to the penis. Sildenafil prevents the degradation of cGMP by PDE5, thereby enhancing and sustaining an erection. It is considered the first-line pharmacological treatment for erectile dysfunction (ED). **Analysis of Incorrect Options:** * **Diazepam:** A benzodiazepine used primarily for its anxiolytic, sedative, and muscle-relaxant properties. It has no role in treating ED and may actually cause sexual dysfunction as a side effect. * **Fluoxetine:** An SSRI used for depression and OCD. It is notorious for causing sexual side effects (decreased libido, delayed ejaculation). Interestingly, it is sometimes used off-label to treat *premature ejaculation*, but not erectile disorder. * **Zolpidem:** A non-benzodiazepine sedative-hypnotic used for the short-term treatment of insomnia. It has no therapeutic effect on erectile function. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** Sildenafil must **never** be co-administered with **nitrates** (e.g., Nitroglycerin) as it can cause life-threatening hypotension. * **Side Effects:** Common side effects include headache, flushing, dyspepsia, and "blue-tinted vision" (cyanopsia) due to weak inhibition of PDE6 in the retina. * **Timing:** It should be taken approximately 30–60 minutes before anticipated sexual activity. * **Other PDE5 Inhibitors:** Tadalafil (longer half-life, "the weekend pill") and Vardenafil.
Question 14: What is frigidity?
- A. Inability to initiate sexual arousal in males
- B. Inability to initiate sexual arousal in females
- C. Inability to initiate and maintain sexual arousal in males
- D. Inability to initiate and maintain sexual arousal in females (Correct Answer)
Explanation: **Explanation:** **Frigidity** is a traditional clinical term used to describe **Female Sexual Interest/Arousal Disorder (FSIAD)**. It is characterized by a persistent or recurrent deficiency (or absence) of sexual fantasies and desire for sexual activity, along with the **inability to initiate or maintain** the physical response of sexual excitement (such as lubrication or swelling) until the completion of the sexual act. 1. **Why Option D is Correct:** The definition of frigidity encompasses both the psychological desire and the physiological arousal phase. It is not merely a failure to start the process but also the failure to sustain the arousal necessary for a satisfactory sexual experience. 2. **Why Options A & C are Incorrect:** These options refer to male sexual dysfunction. The male equivalent of inability to initiate or maintain arousal is **Erectile Dysfunction (ED)** or Impotence. Frigidity is a gender-specific term historically reserved for females. 3. **Why Option B is Incorrect:** While it correctly identifies the gender, it is incomplete. Sexual dysfunction is defined by the failure of the entire arousal cycle, including the maintenance of the response, not just the initiation. **High-Yield Clinical Pearls for NEET-PG:** * **Modern Nomenclature:** In the DSM-5, "Frigidity" and "Hypoactive Sexual Desire Disorder" in women have been merged into **Female Sexual Interest/Arousal Disorder (FSIAD)**. * **Vaginismus:** Often confused with frigidity, this is the involuntary contraction of pelvic floor muscles making penetration painful or impossible, despite potential presence of desire. * **Dyspareunia:** Painful intercourse, which can be a cause or a consequence of arousal disorders. * **Common Causes:** Psychogenic factors (anxiety, past trauma) are most common, but organic causes like menopause (atrophic vaginitis) and drugs (SSRIs, OCPs) must be ruled out.
Question 15: Bremelanotide is used for which of the following conditions?
- A. Hypoactive sexual desire disorder (Correct Answer)
- B. Lower urinary tract symptoms
- C. Hormone refractory prostate cancer
- D. Metastatic renal cell carcinoma
Explanation: **Explanation:** **Bremelanotide** is a novel pharmacotherapy approved for the treatment of **Hypoactive Sexual Desire Disorder (HSDD)** in premenopausal women. **1. Why Option A is Correct:** Bremelanotide is a **melanocortin receptor agonist** (specifically targeting the MC4 receptor). Unlike Flibanserin (which acts on serotonin receptors), Bremelanotide works by modulating brain pathways involved in sexual desire and arousal. It is administered as a **subcutaneous injection** into the abdomen or thigh at least 45 minutes before anticipated sexual activity. It is indicated only for "acquired, generalized" HSDD, not for desire disorders caused by relationship issues or medical/psychiatric conditions. **2. Why Other Options are Incorrect:** * **Option B (LUTS):** Lower urinary tract symptoms are typically managed with alpha-blockers (e.g., Tamsulosin) or 5-alpha reductase inhibitors (e.g., Finasteride). * **Option C (Prostate Cancer):** Hormone refractory prostate cancer is treated with agents like Abiraterone, Enzalutamide, or Cabazitaxel. * **Option D (Renal Cell Carcinoma):** Metastatic RCC is managed with tyrosine kinase inhibitors (e.g., Sunitinib) or immunotherapy (e.g., Nivolumab). **High-Yield Clinical Pearls for NEET-PG:** * **FDA Approval:** Approved in 2019 (Brand name: Vyleesi). * **Mechanism:** MC4 receptor agonist. * **Route:** Subcutaneous (on-demand), unlike Flibanserin which is oral (daily). * **Side Effects:** The most common side effect is **nausea**. It can also cause a transient increase in blood pressure and focal hyperpigmentation (melasma). * **Contraindication:** Patients with uncontrolled hypertension or known cardiovascular disease.
Question 16: Which of the following is the drug of choice for Hypoactive sexual desire disorder in females?
- A. Sildenafil
- B. Flibanserin (Correct Answer)
- C. Mianserin
- D. Lorcaserin
Explanation: **Explanation:** **Hypoactive Sexual Desire Disorder (HSDD)** in females is characterized by a persistent or recurrent deficiency of sexual fantasies and desire for sexual activity, causing marked distress. **1. Why Flibanserin is Correct:** Flibanserin is the first FDA-approved drug specifically for the treatment of HSDD in premenopausal women. It is a **multifunctional serotonin agonist-antagonist (MSAA)**. Its mechanism involves: * **Agonism** at 5-HT1A receptors. * **Antagonism** at 5-HT2A receptors. This action results in a decrease in serotonin (which inhibits sexual desire) and an increase in dopamine and norepinephrine (which stimulate sexual desire) in the prefrontal cortex. **2. Analysis of Incorrect Options:** * **A. Sildenafil:** A PDE-5 inhibitor used for erectile dysfunction in males. It has no proven efficacy in increasing sexual desire in females. * **C. Mianserin:** A tetracyclic antidepressant with sedative properties; it is not indicated for sexual dysfunction and may actually cause sexual side effects. * **D. Lorcaserin:** A selective 5-HT2C receptor agonist previously used as an anorexiant (weight loss drug), now largely withdrawn from several markets due to safety concerns. **3. High-Yield Clinical Pearls for NEET-PG:** * **Bremelanotide:** Another approved treatment for HSDD; it is a **Melanocortin receptor agonist** administered via subcutaneous injection. * **Contraindication:** Flibanserin should not be taken with **alcohol** due to the risk of severe hypotension and syncope. * **Administration:** Flibanserin is taken **once daily at bedtime** to mitigate side effects like dizziness and somnolence. * **Diagnosis:** HSDD is only diagnosed if the lack of desire is not due to a co-existing psychiatric condition, relationship issues, or medication side effects.
Question 17: Females with orgasmic difficulties are advised to perform which exercises to strengthen pubococcygeal muscles?
- A. Kegel's exercises (Correct Answer)
- B. Jacobson's stent
- C. Pelvic floor muscle exercises
- D. Johnson's exercises
Explanation: **Explanation:** **Correct Answer: A. Kegel's exercises** The pubococcygeal (PC) muscle is a key component of the levator ani group that supports the pelvic organs and surrounds the vaginal opening. During female orgasm, this muscle undergoes involuntary, rhythmic contractions. Strengthening the PC muscles through **Kegel’s exercises** increases local blood flow, enhances neuromuscular control, and improves the intensity and frequency of orgasmic responses. These exercises involve repetitive voluntary contraction and relaxation of the pelvic floor muscles and are the first-line behavioral therapy for female orgasmic disorder. **Analysis of Incorrect Options:** * **B. Jacobson’s stent:** This is a distractor. Jacobson’s progressive muscle relaxation is a technique for stress reduction, but there is no medical entity known as "Jacobson's stent" related to pelvic health. * **C. Pelvic floor muscle exercises:** While Kegel’s exercises *are* a type of pelvic floor muscle exercise, "Kegel's" is the specific eponym and medically standard term used in clinical practice and examinations for this specific therapeutic indication. * **D. Johnson’s exercises:** This is a distractor and does not refer to a recognized medical exercise for sexual dysfunction. **NEET-PG High-Yield Pearls:** * **Primary Indication:** Apart from sexual dysfunction, Kegel’s exercises are the gold standard for managing **Stress Urinary Incontinence (SUI)** and mild **Pelvic Organ Prolapse (POP)**. * **Mechanism:** They specifically target the **Levator Ani** muscle group (Pubococcygeus, Puborectalis, and Iliococcygeus). * **Clinical Tip:** Patients are often taught to identify the correct muscle by attempting to "stop the flow of urine" mid-stream (though they should not do this regularly while voiding).
Question 18: Hymenal tear following first sexual intercourse most commonly occurs at which position:
- A. 11 o'clock
- B. 6 o'clock (Correct Answer)
- C. 12 o'clock
- D. All of the above
Explanation: ***Correct: 6 o'clock*** - The **hymen** is most commonly torn at the **6 o'clock position** (inferiorly) due to the direction of typical coital forces during first intercourse. - This area is usually the **thinnest** and **least supported**, making it more susceptible to tearing during initial penetration. - This is the most consistently reported site for initial hymenal tears in forensic and gynecological literature. *Incorrect: 11 o'clock* - While hymenal tears can occur at other positions, the **11 o'clock position** is not the most common site of rupture during first intercourse. - Tears at superior or lateral positions are less frequent unless there are unusual circumstances or anatomical variations. *Incorrect: 12 o'clock* - The **12 o'clock position** (superiorly) is less commonly the primary site of hymenal rupture during first intercourse. - The majority of tears are observed inferiorly (at 6 o'clock) due to the anatomy and mechanics of penetration. *Incorrect: All of the above* - While it is possible for the hymen to tear at **multiple positions** or in various configurations, the question asks for the *most common* position. - The 6 o'clock position is the most consistently reported site for initial hymenal tears, not all positions equally.
Question 19: Which condition is most commonly associated with female sexual dysfunction characterized by painful intercourse?
- A. Absence of ovary
- B. Vaginismus (Correct Answer)
- C. Gonadal dysgenesis
- D. Intersex condition
Explanation: ***Vaginismus*** - **Vaginismus** is a condition characterized by involuntary spasms of the muscles surrounding the vaginal opening, leading to painful intercourse (**dyspareunia**) or inability to complete penetration. - It's a common cause of female sexual dysfunction where the primary symptom is **pain or difficulty with vaginal penetration**. *Absence of ovary* - The **absence of ovaries** primarily affects hormone production and fertility but does not directly cause involuntary vaginal muscle spasms leading to painful intercourse. - While it can lead to vaginal atrophy due to lack of estrogen, which might cause painful intercourse, it's not the most direct or common cause of the specific dysfunction described. *Gonadal dysgenesis* - **Gonadal dysgenesis** refers to abnormal development of the gonads, often leading to hormonal imbalances and infertility. - This condition is not typically associated with muscle spasms causing painful intercourse; its main manifestations are related to sexual development and endocrine function. *Intersex condition* - An **intersex condition** involves atypical development of internal and external sexual anatomy. - While intersex conditions can lead to a variety of sexual health issues, they do not inherently or most commonly present with the involuntary vaginal muscular spasms characteristic of vaginismus.
Practice by Chapter
Female Sexual Response Cycle
Practice Questions
Desire Disorders
Practice Questions
Arousal Disorders
Practice Questions
Orgasmic Disorders
Practice Questions
Sexual Pain Disorders
Practice Questions
Impact of Gynecologic Conditions on Sexual Function
Practice Questions
Psychological Aspects of Female Sexuality
Practice Questions
Hormonal Influences on Sexual Function
Practice Questions
Evaluation of Female Sexual Dysfunction
Practice Questions
Treatment Approaches to Sexual Dysfunction
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free